• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
OCC 1.32% 38.5¢

ORTHOCELL LIMITED

Orthocell Limited is an Australia-based regenerative medicine company. The Company is... Orthocell Limited is an Australia-based regenerative medicine company. The Company is focused on regenerating mobility for patients by developing products for the repair of a variety of bone and soft tissue injuries. Its portfolio of products includes CelGro, Striate+, Remplir, and SmrtGraft. CelGro is a collagen medical device that facilitates tissue reconstruction and healing in a variety of dental and orthopedic reconstructive applications. CelGro is manufactured using a SMRT manufacturing process to preserve the natural collagen structure. Striate+ is used for dental GBR applications. Remplir is for peripheral nerve reconstruction. SmrtGraft is for tendon repair. Its other major products are autologous cell therapy, which focuses on regenerating damaged tendon and cartilage tissue. It is engaged in the development of its tendon cell therapy in the United States. Its autologous tendon therapy is an advanced injectable cellular therapy for the treatment of chronic tendon injuries.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
OCC 16/05/24 29 5.9K
16/05/24 Last post  KainCarver Comments Created with Sketch.  29  Views Created with Sketch.  5.9K 
OCC
OCC Trading
26 27 28
15/05/24 1.6K 475K
15/05/24 Last post  flummoxedtrader Comments Created with Sketch.  1.6K  Views Created with Sketch.  475K 
OCC
Media thread
7 8 9
15/05/24 518 161K
TRENDING NEWS

Retail Revolution: Shekel Brainweigh leads the charge

SBW
16 May 2024
SHEKEL BRAINWEIGH LTD
15/05/24 Last post  KainCarver Comments Created with Sketch.  518  Views Created with Sketch.  161K 
OCC 07/05/24 5 1.5K
07/05/24 Last post  MikesLM Comments Created with Sketch.  5  Views Created with Sketch.  1.5K 
OCC 02/05/24 13 4.0K
02/05/24 Last post  flummoxedtrader Comments Created with Sketch.  13  Views Created with Sketch.  4.0K 
OCC
Stem Cell Therapy advancements
6 7 8
27/04/24 456 148K
27/04/24 Last post  flummoxedtrader Comments Created with Sketch.  456  Views Created with Sketch.  148K 
OCC 25/04/24 15 4.9K
25/04/24 Last post  scolloymore Comments Created with Sketch.  15  Views Created with Sketch.  4.9K 
OCC 24/04/24 4 939
24/04/24 Last post  rae915 Comments Created with Sketch.  4  Views Created with Sketch.  939 

See All Discussions arrow Created with Sketch.

Timeline

Outstanding 98.6% Success Rate in Striate Implant Study
14 May 09:05
 
Compelling 85% Success Rate Remplir Study now published
30 Apr 09:49
 
Change of Director's Interest Notice-John Van Der Wielen
24 Apr 11:52
 
Securities Trading Policy
24 Apr 11:23
 
Change of Director's Interest Notice-John Van Der Wielen
16 Apr 08:56
 
Orthocell receives $3.05m R&D tax incentive refund
15 Apr 09:03
 
View More arrow Created with Sketch.
(20min delay)
Last
38.5¢
Change
0.005(1.32%)
Mkt cap ! $80.59M
Open High Low Value Volume
38.0¢ 38.5¢ 38.0¢ $10.3K 26.83K

Buyers (Bids)

No. Vol. Price($)
2 3551 38.5¢
 

Sellers (Offers)

Price($) Vol. No.
39.0¢ 14559 1
View Market Depth
Last trade - 13.46pm 16/05/2024 (20 minute delay) ?
Last
38.5¢
  Change
0.005 ( 0.00 %)
Open High Low Volume
38.0¢ 38.5¢ 38.0¢ 18729
Last updated 13.46pm 16/05/2024 ?
OCC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.